Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Vulvar Neoplasms 1Vaginal Neoplasms 1Precancerous Conditions 1Papillomavirus Infections 1Multiple Myeloma 1Leukemia, Plasma Cell 1Esophageal Neoplasms 1Barrett Esophagus 1Atypical Squamous Cells of the Cervix 1Adenocarcinoma Of Esophagus 1

Interventions

Endoscopy, Digestive System 3Endoscopy 3Radiotherapy 2Biopsy 2chlorhexidine gluconate 1Specimen Handling 1Risk Assessment 1Radiation 1Nivolumab 1Mass Screening 1Magnetic Resonance Spectroscopy 1Immune Checkpoint Inhibitors 1High-Throughput Screening Assays 1High-Intensity Interval Training 1Hematologic Tests 1Gene Expression Profiling 1Fluorodeoxyglucose F18 1Fecal Microbiota Transplantation 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Endoscopic Mucosal Resection 1Drug Therapy 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Adenocarcinoma Of Esophagus × High-Throughput Screening Assays × Clear all
NCT00987857 2017-08-22

Endoscopy Every 2 Years or Only as Needed in Monitoring Patients With Barrett Esophagus

Gloucestershire Hospitals NHS Foundation Trust

Phase NA Unknown
3,400 enrolled
GastrointestinalOther neoplasm

Adenocarcinoma Of Esophagus, Barrett Esophagus, Esophageal Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡